These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of GM-CSF secretion by topical corticosteroids and nedocromil sodium. A comparison study using nasal polyp epithelial cells. Mullol J; Roca-Ferrer J; Xaubet A; Raserra J; Picado C Respir Med; 2000 May; 94(5):428-31. PubMed ID: 10868704 [TBL] [Abstract][Full Text] [Related]
3. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Mullol J; Xaubet A; López E; Roca-Ferrer J; Picado C Thorax; 1995 Mar; 50(3):270-4. PubMed ID: 7660341 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Xaubet A; Mullol J; López E; Roca-Ferrer J; Rozman M; Carrión T; Fabra JM; Picado C Clin Exp Allergy; 1994 Apr; 24(4):307-17. PubMed ID: 8039016 [TBL] [Abstract][Full Text] [Related]
6. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival. Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266 [TBL] [Abstract][Full Text] [Related]
7. Fluticasone furoate inhibits cytokine secretion from nasal epithelial cells and reduces eosinophil survival in an in vitro model of eosinophilic inflammation. Mullol J; Pujols L; Alobid I; Pérez-Gonzalez M; Fuentes M; de Borja Callejas F; Valero A; Picado C; Roca-Ferrer J Int Arch Allergy Immunol; 2014; 163(3):225-33. PubMed ID: 24603043 [TBL] [Abstract][Full Text] [Related]
8. Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. Xaubet A; Mullol J; Roca-Ferrer J; Pujols L; Fuentes M; Pérez M; Fabra JM; Picado C Respir Med; 2001 May; 95(5):408-14. PubMed ID: 11392584 [TBL] [Abstract][Full Text] [Related]
11. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein. Powell N; Till SJ; Kay AB; Corrigan CJ Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953 [TBL] [Abstract][Full Text] [Related]
12. Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells. Mullol J; de Borja Callejas F; Martínez-Antón MA; Méndez-Arancibia E; Alobid I; Pujols L; Valero A; Picado C; Roca-Ferrer J Respir Res; 2011 Feb; 12(1):23. PubMed ID: 21352574 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids. Hagan JB; Kita H; Gleich GJ Clin Exp Allergy; 1998 Aug; 28(8):999-1006. PubMed ID: 9756205 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. Zhang X; Moilanen E; Kankaanranta H Eur J Pharmacol; 2000 Oct; 406(3):325-32. PubMed ID: 11040338 [TBL] [Abstract][Full Text] [Related]
15. [Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells]. Ohnishi M; Takizawa R; Ohkubo K; Yokosima K; Okuda M; Yagi T Arerugi; 1994 Mar; 43(3):441-7. PubMed ID: 8198453 [TBL] [Abstract][Full Text] [Related]
16. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues. Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid. Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226 [TBL] [Abstract][Full Text] [Related]
18. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Cox G; Ohtoshi T; Vancheri C; Denburg JA; Dolovich J; Gauldie J; Jordana M Am J Respir Cell Mol Biol; 1991 Jun; 4(6):525-31. PubMed ID: 2054193 [TBL] [Abstract][Full Text] [Related]
19. An in vitro comparison of commonly used topical glucocorticoid preparations. Stellato C; Atsuta J; Bickel CA; Schleimer RP J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):623-9. PubMed ID: 10482838 [TBL] [Abstract][Full Text] [Related]
20. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin. Walsh GM; Wardlaw AJ J Allergy Clin Immunol; 1997 Aug; 100(2):208-15. PubMed ID: 9275142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]